Patent · US Active

Heterocycle derivatives for treating TRPM3 mediated disorders

US12209081B2 · kind B2 · utility

1Cited by

0References

9Claims

0Family size

Assignee

Katholieke Universiteit Leuven · BE

Inventors

Patrick Chaltin · Zétrud-Lumay, BE
Arnaud Marchand · Leuven, BE
Jean-Christophe Vanherck · Leuven, BE
Thomas Voets · Kessel-Lo, BE
Joris Vriens · Wakkerzeel, BE
Melanie Reich · Aachen, DE
André WELBERS · Cologne, DE

Key dates

Filing date	May 12, 2024
Grant date	Jan 28, 2025
Priority date	—
Expiry date	May 12, 2044

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/04
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The invention relates to compounds that are useful for the prevention or treatment of TRPM3 mediated disorders, more in particular disorders selected from pain and inflammatory hypersensitivity. The invention also relates to a method for the prevention or treatment of said TRPM3 mediated disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.